86 results
Endovascular treatment for acute chronic heart failure
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex endovascular cases for the treatment of acute chronic heart failure, including the use of 3D printing and virtual reality to close a pulmonary arteriovenous malformation, closure of a post-septal myectomy ventricular septal defect, and catheter-based treatment of a heart...
Mechanical circulatory support in cardiogenic shock and high-risk PCI
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on the use of mechanical circulatory support in cardiogenic shock and high-risk PCI. It includes presentations and discussions on lowering cardiogenic shock mortality through a comprehensive mechanical circulatory support approach, the use of lactate and lactate clearance...
What is the optimal management of patients with coronary artery disease and left ventricle dysfunction in 2024?
15 May 2024 – From EuroPCR 2024
Check out this EuroPCR 2024 interview between Valeria Paradies and Vasileios Panoulas to learn about CAD patients with LV dysfunction. Gain insights from the REVIVED trial, which shows that very stable, asymptomatic patients can be treated with medical therapy, including the four pillars of heart failure...
Mechanical circulatory support in cardiogenic shock: where are we now?
14 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 interview, Alaide Chieffo and Gabor Toth discuss mechanical circulatory support in cardiogenic shock and myocardial infarction. They address the ECLS-SHOCK trial's lack of benefit from prophylactic ECMO, stressing improved patient selection and timing. They contrast this with the DanGer Shock study, where...
Innovations in heart failure: moving the heart forward
13 May 2024 – From EuroPCR 2024
CSL112 (Apolipoprotein A-I) infusions and cardiovascular outcomes in patients with acute myocardial infarction (ApoA-I event reducing in ischemic syndromes II (AEGIS-II) Trial): Primary trial results
06 Apr 2024
Luis Ortega-Paz interviews C. Michael Gibson about the AEGIS-II primary trial results which he presented at ACC.24 in Atlanta.
ApoA-I post-heart attack showed no reduction in 90-day death or heart attack risk. However, exploratory analysis hints at benefits at one year, suggesting potential for longer-term efficacy.
Author
Author
Empagliflozin after acute myocardial infarction: Results of the EMPACT-MI Trial
07 Apr 2024
Mirvat Alasnag interviews Javed Butler about the EMPACT-MI trial which he presented at ACC.24 in Atlanta.
Among patients at increased risk for heart failure after acute MI, treatment with empagliflozin did not lead to a significantly lower risk of first hospitalization for heart failure or death from any...
Author
Author
Percutaneous transvalvular micro-axial flow pump in infarct related cardiogenic shock: Results of the DANGER-shock Trial
07 Apr 2024
Mirvat Alasnag interviews Jacob Eifer Møller about the results of the DANGER-shock Trial which he presented at the ACC.24 in Atlanta.
Results show that the implantation of microaxial flow pump post-heart attack significantly boosts survival in patients with STEMI-related cardiogenic shock, though with increased complications. The trial's positive...
Author
Author
PCRonline @ ACC.24 Scientific Sessions
22 Mar 2024
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2024 Scientific Sessions #ACC24
How to perform angiographic check after large-sheath removal in single access procedures
18 Mar 2024
In the absence of other arterial access, this step-by-step tutorial shows how to perform anterograde angiography of the arterial axis after removal of the large sheath, making it easier to recognise and rapidly manage vascular complications such as arterial lesions and haemostasis failure.
Author
Author
Author
Author
Author
Author
Author
Author
